Sihil Pantopet Injection 40mg

Sihil Pantopet Injection 40mg 

Sihil Pantopet Injection (Pantoprazole 40mg) is a clinically formulated intravenous proton pump inhibitor (PPI) designed to provide rapid and effective reduction of stomach acid. Ideal for hospital and critical care settings, it is used when oral administration is not feasible.

Active Ingredient: Pantoprazole 40mg per vial
Therapeutic Class: Proton Pump Inhibitor (PPI)

Mechanism of Action:
Sihil Pantopet Injection selectively inhibits the H+/K+ ATPase enzyme system (proton pump) in gastric parietal cells, blocking the final step of acid production. Rapid onset ensures effective acid control within 1 hour of administration.

Indications & Uses:

• Gastroesophageal Reflux Disease (GERD): Relief from severe acid reflux, heartburn, and esophageal irritation.

• Peptic Ulcer Disease: Promotes healing of gastric and duodenal ulcers.

• Zollinger-Ellison Syndrome: Controls excessive gastric acid production.

• Critical Care: Prevents stress-related gastric ulcers in critically ill patients.

• Pre-operative Use: Helps prevent aspiration-related complications during surgery.

Administration:

• Administered intravenously by healthcare professionals only.

• Not intended for self-administration.

Side Effects & Precautions:

• Common side effects: Nausea, headache, dizziness, diarrhea, constipation, abdominal discomfort, flatulence, injection site reactions (pain, swelling, redness).

• Long-term use (>1 year) may increase risk of fractures, Vitamin B12 deficiency, or low magnesium (hypomagnesemia).

• Caution advised for patients with severe liver disease, osteoporosis, or those taking certain medications (e.g., HIV drugs).

• Pregnancy and breastfeeding: Use only under medical supervision.

Important Notes:

• Lifestyle adjustments (avoid alcohol, smoking, spicy/fatty foods) can enhance effectiveness.

• Monitoring of liver and kidney function and magnesium levels recommended during long-term use.

Sihil Pantopet Injection is a hospital-strength, fast-acting PPI for effective management of acid-related disorders.